What's new

EMEA-003389-PIP01-23

EMEA-003389-PIP01-23

Mar 17, 2025 - 16:38
 0
EMEA-003389-PIP01-23
EMEA-003389-PIP01-23
Read More

Tags:

Previous Article

Curevo rounds up $110M to challenge GSK’s Shringrix, nabs Moncef Slaoui to lead ...

Next Article

The D Brief: Strikes in Yemen; Border destroyer; DOGE vs. nuclear-security agenc...

Related Posts

Herbal medicinal product: Oleae folium, Olea europaea L., C: ongoing call for scientific data

Herbal medicinal product: Oleae folium, Olea europaea L...

Mar 13, 2025  0

Human medicines European public assessment report (EPAR): Ultibro Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 19/09/2013, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0

Human medicines European public assessment report (EPAR): Epruvy (previously Ranibizumab Midas), ranibizumab, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0